Introduction
Benzyl alcohol is frequently used as a bacteriostatic agent or co-solvent in a variety of liquid pharmaceutical preparations. The main oxidation product is benzaldehyde, occurring as a result of oxidation upon long-term storage, or heat sterilization of parenteral dosage forms containing benzyl alcohol, if oxygen is not excluded by nitrogen flushing. 1 The sonication of solutions containing benzyl alcohol also generates benzaldehyde. 2 It is known that prolonged exposure of nerve fiber (either in isolation or in experimental animals) to benzyl alcohol results in extensive degeneration and demyelination, though the causative agent has not been positively identified. [3] [4] [5] Evidence to date suggests that benzaldehyde containing sting of the Apheloria arthropods (millipedes) causes a similar neurotoxic symptom. Commercial pharmaceutical preparations of Na-diclofenac include injection formulations that contain benzyl alcohol as a preservative or co-solvent in the concentration range up to 5%. In Iran, a warning was issued by the Ministry of Health to medical practitioners and hospitals that in a single year (2000) nearly 200 cases of paraplegia had resulted from the use of generic brands of Na-diclofenac injections. Several other gas 6, 7 and liquid [8] [9] [10] chromatographic methods, as well as derivative UV spectrometry 11 and polarography, 12 have been employed for the identification and quantification of benzaldehyde. Recently, Rezaee and coworkers have developed a simple and rapid microextraction method, named dispersive liquid-liquid microextraction (DLLME), and so far it has been applied for the extraction of different compounds.
13,14 DLLME is based on a ternary component solvent system. The dispersion of the extraction solvent (assisted by the disperser solvent) within the aqueous solution leads to the generation of a significantly large contact area between the extraction solvent and the aqueous phase. In the proposed work, the DLLME method was optimized for the determination of benzaldehyde in injectable solution samples.
Experimental

Reagents and standards
Benzaldehyde, carbon tetrachloride, tetrachloroethylene, chloroform, 1,2-dichloroethane, dichloromethane, 1,2-dichloroethene, carbon disulfide, acetone, acetonitrile, methanol and reagent-grade NaCl were obtained from Merck (Darmstadt, Germany). An appropriate amount of benzaldehyde was dissolved in 10.0 mL of methanol to obtain a standard stock solution with a concentration of 100 mg L -1 . A fresh 10 mg L -1 standard solution containing benzaldehyde was prepared in methanol every week and stored at 4 C. Various batches of generic Na-diclofenac, vitamin B-complex and Voltaren injection formulation solutions were kindly supplied by the following manufactures in Iran: EXIR-IRAN, DAROU PAKHSH.
Instrumentation
A gas chromatograph (Agilent GC-7890) equipped with a split/splitless injector system and flame ionization detector was A rapid and sensitive method has been developed for the determination of benzaldehyde, a toxic oxidation product of the widely used preservative and co-solvent benzyl alcohol in injectable formulations of non-steroidal anti-inflammatory drugs, diclofenac, vitamin B-complex and Voltaren injection solutions by using dispersive liquid-liquid microextraction followed by gas chromatography. This method involves the use of an appropriate mixture of extraction solvent (43.0 μL 1,2-dichloroethane) and disperser solvent (1.0 mL acetonitrile) for the formation of a cloudy solution in a 5.0-mL aqueous sample containing benzaldehyde. The linear range was 1.0 -1000 μg L Notes used for the separation and determination of benzaldehyde. Ultra-pure helium gas (99.999%, Air Products, UK) was passed through a molecular sieve and oxygen trap (Crs, USA), and was used as a carrier gas with a flow rate of 2 mL min -1 . The injection port was held at 250 C and operated in the splitless mode for 1 min; then, a split valve was opened, and a split ratio of 1:5 was applied. Separation was carried out on a DB5, 25 m × 0.32 mm i.d. and 0.25 μm film thickness from SGE (Victoria, Australia) capillary column. The oven temperature was kept at 70 C for 3 min, and then increased to 100 C at a rate of 5 C/min; it was held for 2 min, and then increased to 250 C at a rate of 20 C/min, and was held for 1 min. The FID oven temperature was maintained at 270 C. Hydrogen was generated by a hydrogen generator (OPGU-2200S, Shimadzu) for FID at a flow rate of 30 mL min -1 . The flow of air (99.999%, Air Products) for FID was 400 mL min -1 . The Model 2010 D Centurion Scientific centrifuge (Westsussex, UK) was used for separation of the sediment phase from the sample solution.
DLLME procedure
First, 5.0 mL of double distilled water was placed in a 10-mL screw cap glass test tube with conical bottom and spiked at the level of 100 μg L -1 by benzaldehyde. Then, 1.0 mL of acetonitrile (as disperser solvent) containing 43.0 μL of 1,2-dichloroethane (as extraction solvent) was injected into a sample solution, rapidly. It was then centrifuged for 3 min at 5000 rpm. After that, 2.0 μL of the sedimented phase was injected into GC for analysis.
Results and Discussion
In this work, DLLME followed by GC-FID were applied for the extraction and determination of benzaldehyde in injectable solution drugs. The preconcentration factor and the extraction recovery were calculated based on the following equation:
where PF, Csed and C0 are the preconcentration factor, the concentration of the analyte in the sedimented phase and the initial concentration of the analyte in the aqueous sample, respectively.
Hence, ER, Vsed and Vaq are the extraction recovery, and the volumes of the sedimented phase and the aqueous sample, respectively. Csed was calculated from a suitable calibration curve obtained by direct injection of benzaldehyde standard solutions with the concentration in the range of 10 -1000 mg L -1 . The relative recovery (RR) was obtained from
where Cfound, Creal and Cadded are the concentrations of the analyte after the addition of a known amount of standard in a real sample, the concentration of the analyte in a real sample and the concentration of a known amount of standard, which was spiked to the real sample, respectively. The results (Fig. 1) show that 1,2-dichloroethane had the highest extraction efficiency for benzaldehyde compared with other solvents.
Selection of the extraction and disperser solvent
Therefore, 1,2-dichloroethane was chosen as the extraction solvent in further experiments. Acetone, acetonitrile and methanol were examined as the disperser solvent. A series of sample solutions containing 100.0 μg L -1 of benzaldehyde were prepared and extracted using 1.0 mL of each disperser solvent containing 43.0 μL of 1,2-dichloroethane. The extraction recoveries using acetone, acetonitrile and methanol for benzaldehyde were 64, 66 and 65%, respectively. According to the results, the extraction recoveries varied slightly with different disperser solvents. However, a cleaner chromatogram was obtained in the presence of acetonitrile. Due to this reason, acetonitrile was selected as the disperser solvent.
Effect of the extraction and disperser solvent volume
To examine the effect of the extraction solvent volume, the experimental conditions were fixed, and included the use of 1.0 mL acetonitrile containing different volumes of 1,2-dichloroethane (43.0, 48.0, 53.0 and 58.0 μL). By increasing the volume of 1,2-dichloroethane from 43.0 to 58.0 μL, the volume of the sedimented phase increased, and thereby the preconcentration factor decreased due to dilution of the sedimented phase, as shown in Fig. 2 . Therefore, the highest preconcentration factor and extraction recovery (Fig. 2) were achieved by using a lower volume of the extraction solvent (43.0 μL of 1,2-dichloroethane). To examine the effect of the disperser solvent volume, the experimental conditions were fixed and included the use of different volumes of acetonitrile (0.5, 1.0, 1.5 and 2.0 mL) containing 40.0, 43.0, 47.0 and 52.0 μL of 1,2-dichloroethane, respectively. Under these conditions, the volume of the sedimented phase was constant (5.0 ± 0.3 μL). The results are given in Fig. 3 . Accordingly, the extraction recovery increased by increasing the acetonitrile volume up to 1.0 mL, and then decreased by increasing the volume of acetonitrile. It seems that at a low volume of acetonitrile, a cloudy state was not formed well; thereby, the extraction recovery decreased. At a high volume of acetonitrile, the solubility of benzaldehyde in water increased; therefore, the extraction recovery decreased. Thus, 1.0 mL of acetonitrile was chosen as the optimum volume in further work.
Effect of the ionic strength and the extraction time
To investigate the influence of the ionic strength, different amounts of NaCl (0 -8% (w/v)) were used where all other experimental conditions were kept constant. The extraction recoveries ranged from 63 to 66%. Therefore, the extraction recoveries did not significantly change with the addition of salt. Therefore, the extraction experiments were carried out without salt addition. The effect of the extraction time was examined over the range of 0 -40 min under constant conditions. The extraction recoveries did not change for the analytes within that period of time.
Quantitative analysis
The calibration graph for the peak area against the concentration of benzaldehyde was constructed using the optimum conditions. The equation of this curve (y = 18.94x -36.69) was then used to calculate the unknown benzaldehyde concentration. Linearity was observed over the range of 1.0 -1000 μg L -1 for the analyte. The coefficient of determination (r 2 ) was 0.9993 for benzaldehyde. The extraction recovery was 65.0% and the preconcentration factor at a concentration analyte of 100.0 μg L -1 was 650 in this method for benzaldehyde.
The relative standard deviation (RSD, n = 4) at the level of 10.0 μg L -1 of benzaldehyde was 5.4%. The limit of detection (LOD), based on the signal-to-noise ratio (S/N) of 3 was 0.2 μg L -1 for the analyte. The selectivity of this method was checked by monitoring standard solutions of benzaldehyde in the presence of formulation components of the diclofenac, vitamin B-complex and Voltaren injection formulations separately. The ability of the system to resolve benzaldehyde from potentially interfering components was good. The responses were not different from that obtained in the calibration. Hence, the determination of benzaldehyde in these formulations is considered to be free from interference due to formulation components.
Real sample analysis
In order to test the applicability of the proposed method, three injection formulation solution samples were extracted and analyzed under the optimum conditions (disperser solvent (acetonitrile) volume, 1.0 mL; extraction solvent (1,2-dichloroethane) volume, 43.0 μL; without salt addition). In order to reduce the matrix effect, the three real samples were diluted to 1:10, using deionized water. Then, the real samples were spiked with a benzaldehyde standard solution (0.2 mg L -1 concentration level) to assess the matrix effects. The obtained relative recoveries were between 90.0 and 95.0% (Table 1) . The results show that the matrix had a negligible effect on DLLME of benzaldehyde. 
Conclusions
The performance of the DLLME procedure in the extraction of benzaldehyde from three injectable solutions (Na-diclofenac, vitamin B-complex and Voltaren) is excellent. The proposed method provides good repeatability, high recovery and preconcentration factor within a very short time. The newly developed microextraction technique has distinct advantages over the conventional method with respect to the extraction time, volume of solvents required and low detection limit.
